Skip to product information
1 of 1

Shulph Ink

Horizons in Cancer Research: Volume 81

Horizons in Cancer Research: Volume 81

Dispatches within 7 to 10 working days
Regular price £178.70 GBP
Regular price £221.99 GBP Sale price £178.70 GBP
19% OFF Sold out
Tax included. Shipping calculated at checkout.

YOU SAVE £43.29

  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about Horizons in Cancer Research: Volume 81

This edited volume discusses recent progress in cancer research, including robotic surgery, cytoreductive surgery, ISG15 and protein ISGylation, MCF-7 cells, breast conserving treatment, immune system therapy, and gene therapy for squamous cell carcinoma.

Format: Hardback
Length: 218 pages
Publication date: 23 July 2021
Publisher: Nova Science Publishers Inc


This edited volume presents a comprehensive exploration of recent advancements in cancer research, encompassing seven chapters. Chapter One delves into the application of robotic surgery in radical cystectomy, highlighting patient selection, surgical approach, perioperative and oncologic outcomes, as well as addressing some areas of controversy in the literature. Chapter Two delves into the principles of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy procedures, discussing their potential risks for patients and staff. Chapter Three explores findings related to ISG15 and protein ISGylation, shedding light on their association with interferon signaling in cancer. Chapter Four explores the potential of MCF-7 cells in curbing or counteracting breast cancer. Chapter Five examines the potential of emerging technologies in breast conserving treatment. Chapter Six provides a comprehensive review of the current literature surrounding the basis of employing the immune system for the treatment of non-melanoma skin cancers (NMSC). It discusses approved immunotherapies for each type of NMSC, outlines indications for use, and synthesizes ongoing investigational studies of immunomodulatory agents for these diseases. Finally, Chapter Seven delves into the use of gene therapy in managing squamous cell carcinoma.

This edited volume offers a valuable resource for researchers, clinicians, and healthcare professionals seeking to stay updated on the latest developments in cancer research. The chapters provide in-depth insights into various aspects of cancer treatment, from surgical techniques to immunotherapy, and offer a glimpse into the potential future of cancer management.


ISBN-13: 9781536199178

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details